Financhill
Back

Voyager Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and VYGR is experiencing slight selling pressure.

Voyager Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.95 Sell
20-day SMA: 3.18 Sell
50-day SMA: 3.31 Sell
200-day SMA: 5.25 Sell
8-day EMA: 2.92 Sell
20-day EMA: 3.11 Sell
50-day EMA: 3.43 Sell
200-day EMA: 5.04 Sell

Voyager Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 33.87 Sell
Chaikin Money Flow: -48266 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.98 - 3.52) Sell
Bollinger Bands (100): (3.13 - 5.03) Sell

Voyager Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Voyager Therapeutics Stock

Is Voyager Therapeutics Stock a Buy?

VYGR Technical Analysis vs Fundamental Analysis

Sell
19
Voyager Therapeutics (VYGR) is a Sell

Is Voyager Therapeutics a Buy or a Sell?

Voyager Therapeutics Stock Info

Market Cap:
151.6M
Price in USD:
2.74
Share Volume:
415.1K

Voyager Therapeutics 52-Week Range

52-Week High:
9.55
52-Week Low:
2.65
Sell
19
Voyager Therapeutics (VYGR) is a Sell

Voyager Therapeutics Share Price Forecast

Is Voyager Therapeutics Stock a Buy?

Fundamental Analysis of Voyager Therapeutics

Is Voyager Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.02 per share, a decrease this year of $1.18 per share, and an increase next year of $0.47 per share.

Technical Analysis of Voyager Therapeutics

Should I short Voyager Therapeutics stock?

* Voyager Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.